A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2
Abstract Hepatitis C virus (HCV) entry into hepatocytes is a multistep process that represents a promising target for antiviral intervention. The viral envelope protein E1E2 plays a critical role in HCV entry. In this study, we sought to identify peptide inhibitors of HCV by screening a library of o...
Guardado en:
Autores principales: | Peiqi Yin, Ling Zhang, Fei Ye, Yao Deng, Sha Lu, Yi-Ping Li, Leiliang Zhang, Wenjie Tan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14a535e894574041ba6a7a01d70ccb93 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel small molecule inhibitor of hepatitis C virus entry.
por: Carl J Baldick, et al.
Publicado: (2010) -
Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library
por: Junyuan Cao, et al.
Publicado: (2021) -
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
por: Yunkai Zhu, et al.
Publicado: (2021) -
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease.
por: Jeremy D Baker, et al.
Publicado: (2021) -
A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound
por: Abhilasha Madhvi, et al.
Publicado: (2017)